Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
1989-10-18
pubmed:abstractText
Tumor cells resistant to chloroethylnitrosourea (CENU) therapy contain high levels of O6-alkylguanine DNA-alkyltransferase (GATase), a DNA repair enzyme that aborts DNA interstrand cross-linking by removing CENU-induced O6-alkylguanine adducts. Because the transferase binds covalently to CENU-treated oligonucleotides, we reacted partially purified GATase from cultured human lymphoblasts with a BCNU-treated, 35S-5'-end-labeled, synthetic oligonucleotide designed to have a polyadenylated 3' terminus. Immunoprobing Western blots of this reaction mixture with GATase-specific monoclonal antibody indicated that 25-30% of the transferase became complexed. We purified this complex by affinity chromatography with oligo(dT) cellulose, recovering homogenous material that appeared as a discrete 35-kDa Coomassie blue or silver-stained band after SDS-polyacrylamide gel electrophoresis. Autoradiography and Western immunoblotting confirmed that this band contained both the radiolabeled oligonucleotide and the GATase protein.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3004713, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3079405, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3355582, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3405749, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3679391, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3708569, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3731392, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3814140, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3857628, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3916338, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-3960738, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6325181, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6585269, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6822564, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6870930, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6947250, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-6957878, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-7279663, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-7380020, http://linkedlifedata.com/resource/pubmed/commentcorrection/2780288-7464910
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0305-1048
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6581-90
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Affinity purification and characterization of human O6-alkylguanine-DNA alkyltransferase complexed with BCNU-treated, synthetic oligonucleotide.
pubmed:affiliation
Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38101.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't